METROPOLIS logo

Metropolis Healthcare Limited Stock Price

NSEI:METROPOLIS Community·₹101.5b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 7 Fair Values set on narratives written by author

METROPOLIS Share Price Performance

₹1,959.50
-56.25 (-2.79%)
₹1,655.00
Fair Value
₹1,959.50
-56.25 (-2.79%)
40.0% overvalued intrinsic discount
₹1,400.00
Fair Value
Price ₹1,959.50
AnalystLowTarget ₹1,400.00
AnalystHighTarget ₹2,354.17
AnalystConsensusTarget ₹2,144.53

METROPOLIS Community Narratives

AnalystLowTarget·
Fair Value ₹1.66k 18.4% overvalued intrinsic discount

Digital Testing Will Undermine Traditional Diagnostics Profitability

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystHighTarget·
Fair Value ₹2.35k 16.6% undervalued intrinsic discount

India's Rising Healthcare And Digital Adoption Will Expand Diagnostic Reach

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value ₹2.14k 8.6% undervalued intrinsic discount

Rural Market Expansion And Digitalization Will Transform Diagnostics

0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative

Updated Narratives

METROPOLIS logo

Rural Market Expansion And Digitalization Will Transform Diagnostics

Fair Value: ₹2.14k 8.6% undervalued intrinsic discount
6 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
METROPOLIS logo

Digital Testing Will Undermine Traditional Diagnostics Profitability

Fair Value: ₹1.66k 18.4% overvalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
METROPOLIS logo

India's Rising Healthcare And Digital Adoption Will Expand Diagnostic Reach

Fair Value: ₹2.35k 16.6% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Excellent balance sheet with reasonable growth potential.

0 Risks
1 Reward

Metropolis Healthcare Limited Key Details

₹14.8b

Revenue

₹3.4b

Cost of Revenue

₹11.5b

Gross Profit

₹9.9b

Other Expenses

₹1.6b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
30.53
77.27%
10.67%
1.4%
View Full Analysis

About METROPOLIS

Founded
1980
Employees
4823
CEO
Surendran Chemmenkotil
WebsiteView website
www.metropolisindia.com

Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India, Africa, South Asia, the Middle East, and internationally. The company offers routine and semi-specialised pathology tests; advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; and clinical trial research, hospital lab management, and home collection services, as well as profiles, blood tests, and soft radiology services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, youth, and corporates. In addition, the company develops and deals in technology driven products and services. The company serves a range of customers, including direct-to-consumer diagnostics through patient service centers, a mobile app, a website, and home collection; partnerships with standalone labs, hospital chains, and diagnostic networks; and institutional clients, such as corporates, government bodies, and hospital lab management services. Metropolis Healthcare Limited was founded in 1980 and is headquartered in Mumbai, India.

Recent METROPOLIS News & Updates

Recent updates

No updates